Effects of acetylsalicylic acid on serum paraoxonase activity, Ox-LDL, coenzyme Q10 and other oxidative stress markers in healthy volunteers

被引:24
作者
Kurban, Sevil [1 ]
Mehmetoglu, Idris [1 ]
机构
[1] Selcuk Univ, Meram Tip Fak, Biyokimya AD, TR-42080 Konya, Turkey
关键词
Acetylsalicylic acid; Paraoxonase; Arylesterase; Oxidized LDL; Coenzyme Q(10); Oxidative stress; LOW-DENSITY-LIPOPROTEIN; ASPIRIN; ATHEROSCLEROSIS; SUPEROXIDE; INHIBITION; SALICYLATE; EXPRESSION; INCREASES; DISEASE;
D O I
10.1016/j.clinbiochem.2009.10.054
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The aim of the study was to examine the effects of acetylsalicylic acid (ASA) on oxidative stress in healthy volunteers. Design and Methods: 30 volunteers of which 17 received ASA as 100 mg/day (Group 1) and 13 received ASA as 150 mg/day (Group 11) for 2 months. Serum paraoxonase 1 (PON1), arylesterase, total antioxidant status (TAS), total oxidant status (TOS), oxidized LDL (Ox-LDL) and coenzyme Q(10) (CoQ(10)) levels were measured before and I and 2 months after treatment. Results: There was no significant differences between the measured parameters of the groups. However, TOS and Ox-LDL levels of group 11 were significantly reduced after 2 months of treatment (p<0.05). Conclusions: Significantly inhibition of LDL oxidation and significantly reduction in TOS levels of group II after 2 months of ASA treatment shows that ASA treatment may contribute to the prevention of atherosclerosis, a beneficial effect which is dose and time dependent. (C) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:287 / 290
页数:4
相关论文
共 37 条
[1]   Increases in tissue levels of ubiquinone in association with peroxisome proliferation [J].
Aberg, F ;
Zhang, YY ;
Teclebrhan, H ;
Appelkvist, EL ;
Dallner, G .
CHEMICO-BIOLOGICAL INTERACTIONS, 1996, 99 (1-3) :205-218
[2]   Anti-inflammatory effects of aspirin and sodium salicylate [J].
Amann, R ;
Peskar, BA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 447 (01) :1-9
[3]   Gentisic acid, an aspirin metabolite, inhibits oxidation of low-density lipoprotein and the formation of cholesterol ester hydroperoxides in human plasma [J].
Ashidate, K ;
Kawamura, M ;
Mimura, D ;
Tohda, H ;
Miyazaki, S ;
Teramoto, T ;
Yamamoto, Y ;
Hirata, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 513 (03) :173-179
[4]   Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development [J].
Aviram, M ;
Rosenblat, M .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (09) :1304-1316
[5]   Aspirin [J].
Awtry, EH ;
Loscalzo, J .
CIRCULATION, 2000, 101 (10) :1206-1218
[6]   Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1 [J].
Blatter-Garin, MC ;
Kalix, B ;
De Pree, S ;
James, RW .
DIABETOLOGIA, 2003, 46 (04) :593-594
[7]   The paraoxonases: role in human diseases and methodological difficulties in measurement [J].
Camps, Jordi ;
Marsillach, Judit ;
Joven, Jorge .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2009, 46 (02) :83-106
[8]   Endothelial activation by angiotensin II through NFκB and p38 pathways:: Involvement of NFκB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin [J].
Costanzo, A ;
Moretti, F ;
Burgio, VL ;
Bravi, C ;
Guido, F ;
Levrero, M ;
Puri, PL .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 195 (03) :402-410
[9]   Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin [J].
Cyrus, T ;
Yao, YM ;
Tung, LX ;
Praticò, D .
ATHEROSCLEROSIS, 2006, 184 (01) :8-14
[10]   Role of oxidative stress in cardiovascular diseases [J].
Dhalla, NS ;
Temsah, RM ;
Netticadan, T .
JOURNAL OF HYPERTENSION, 2000, 18 (06) :655-673